CABA
Price
$1.59
Change
-$0.11 (-6.47%)
Updated
Jun 27 closing price
Capitalization
141.21M
38 days until earnings call
FBLG
Price
$0.62
Change
-$0.09 (-12.68%)
Updated
Jun 27 closing price
Capitalization
24.26M
65 days until earnings call
Interact to see
Advertisement

CABA vs FBLG

Header iconCABA vs FBLG Comparison
Open Charts CABA vs FBLGBanner chart's image
Cabaletta Bio
Price$1.59
Change-$0.11 (-6.47%)
Volume$7.97M
Capitalization141.21M
FibroBiologics
Price$0.62
Change-$0.09 (-12.68%)
Volume$3.36M
Capitalization24.26M
CABA vs FBLG Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
CABA vs. FBLG commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CABA is a Buy and FBLG is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (CABA: $1.59 vs. FBLG: $0.62)
Brand notoriety: CABA and FBLG are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CABA: 346% vs. FBLG: 1060%
Market capitalization -- CABA: $141.21M vs. FBLG: $24.26M
CABA [@Biotechnology] is valued at $141.21M. FBLG’s [@Biotechnology] market capitalization is $24.26M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CABA’s FA Score shows that 1 FA rating(s) are green whileFBLG’s FA Score has 0 green FA rating(s).

  • CABA’s FA Score: 1 green, 4 red.
  • FBLG’s FA Score: 0 green, 5 red.
According to our system of comparison, CABA is a better buy in the long-term than FBLG.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CABA’s TA Score shows that 3 TA indicator(s) are bullish while FBLG’s TA Score has 2 bullish TA indicator(s).

  • CABA’s TA Score: 3 bullish, 6 bearish.
  • FBLG’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, both CABA and FBLG are a bad buy in the short-term.

Price Growth

CABA (@Biotechnology) experienced а -11.22% price change this week, while FBLG (@Biotechnology) price change was -11.14% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

CABA is expected to report earnings on Aug 07, 2025.

FBLG is expected to report earnings on Sep 03, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CABA($141M) has a higher market cap than FBLG($24.3M). CABA YTD gains are higher at: -29.991 vs. FBLG (-69.095). FBLG has higher annual earnings (EBITDA): -7.05M vs. CABA (-123.92M). CABA has more cash in the bank: 132M vs. FBLG (8.67M). FBLG has less debt than CABA: FBLG (7.12M) vs CABA (28.8M). CABA (0) and FBLG (0) have equivalent revenues.
CABAFBLGCABA / FBLG
Capitalization141M24.3M580%
EBITDA-123.92M-7.05M1,757%
Gain YTD-29.991-69.09543%
P/E RatioN/AN/A-
Revenue00-
Total Cash132M8.67M1,523%
Total Debt28.8M7.12M405%
TECHNICAL ANALYSIS
Technical Analysis
CABAFBLG
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
83%
Momentum
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 4 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
90%
Advances
ODDS (%)
Bullish Trend 18 days ago
88%
N/A
Declines
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
84%
N/A
Aroon
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CABA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FBLG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLCGY41.460.49
+1.20%
Clicks Group Ltd
KUBTY56.060.39
+0.69%
Kubota Corp.
AMNCB0.03N/A
N/A
Amincor Inc
SVIN4.10N/A
N/A
Scheid Vineyards Inc.
UELKY22.14N/A
N/A
Ulker Biskuvi Sanayi AS

CABA and

Correlation & Price change

A.I.dvisor indicates that over the last year, CABA has been loosely correlated with IPSC. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if CABA jumps, then IPSC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CABA
1D Price
Change %
CABA100%
-6.52%
IPSC - CABA
44%
Loosely correlated
-5.74%
KYTX - CABA
43%
Loosely correlated
-5.48%
ARCT - CABA
42%
Loosely correlated
-7.49%
AUTL - CABA
42%
Loosely correlated
N/A
ARWR - CABA
42%
Loosely correlated
+0.06%
More

FBLG and

Correlation & Price change

A.I.dvisor indicates that over the last year, FBLG has been loosely correlated with ENTO. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if FBLG jumps, then ENTO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FBLG
1D Price
Change %
FBLG100%
-13.19%
ENTO - FBLG
37%
Loosely correlated
-12.87%
CABA - FBLG
34%
Loosely correlated
-6.52%
CCCC - FBLG
31%
Poorly correlated
-7.89%
TERN - FBLG
31%
Poorly correlated
-4.25%
ARQT - FBLG
29%
Poorly correlated
-4.58%
More